Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04546984
What this trial is testing

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Sunshine Lake Pharma Co., Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT04805398
What this trial is testing

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Who this might be right for
Chronic Rhinosinusitis (Diagnosis)Nasal Polyps
Keymed Biosciences Co.Ltd 56
Early research (Phase 1)Study completedNCT01711463
What this trial is testing

Relovair PD PK in Chinese Healthy Subjects

Who this might be right for
Asthma
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT03724916
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Erythematosus, Systemic
Millennium Pharmaceuticals, Inc. 23
Early research (Phase 1)Not Yet RecruitingNCT07606521
What this trial is testing

A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus

Who this might be right for
Multiple Sclerosis
Polpharma Biologics International AG 222
Testing effectiveness (Phase 2)Study completedNCT01972152
What this trial is testing

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

Who this might be right for
Hypoglycemia
Xeris Pharmaceuticals 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06175065
What this trial is testing

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
ReAlta Life Sciences, Inc. 24
Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Early research (Phase 1)Study completedNCT06453824
What this trial is testing

SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

Who this might be right for
Safety and Tolerability
MDI Therapeutics, Inc. 48
Testing effectiveness (Phase 2)WithdrawnNCT01773174
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT04231513
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants

Who this might be right for
Healthy Volunteers
Eisai Inc. 72
Early research (Phase 1)UnknownNCT05765006
What this trial is testing

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02553889
What this trial is testing

Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis

Who this might be right for
End-stage Renal Disease (ESRD)
Ionis Pharmaceuticals, Inc. 49
Early research (Phase 1)Study completedNCT04690868
What this trial is testing

Compare PK, PD and Safety of the AD-213-A and AD-2131

Who this might be right for
Gastroesophagus Reflux Disease
Addpharma Inc. 43
Early research (Phase 1)Study completedNCT02705989
What this trial is testing

Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 439
Early research (Phase 1)Study completedNCT04999527
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects

Who this might be right for
Healthy Volunteer
Disc Medicine, Inc 42
Early research (Phase 1)Study completedNCT01951027
What this trial is testing

Phase I Study GX-G3 in Healthy Subjects

Who this might be right for
Healthy
Genexine, Inc. 53
Early research (Phase 1)Study completedNCT03276858
What this trial is testing

Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Crinetics Pharmaceuticals Inc. 99
Early research (Phase 1)Study completedNCT02460146
What this trial is testing

PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects

Who this might be right for
Acute Kidney Injury
Complexa, Inc. 43
Early research (Phase 1)Study completedNCT04116840
What this trial is testing

Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection

Who this might be right for
Healthy
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation